microRNA-222 promotes colorectal cancer cell migration and invasion by targeting MST3

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Metastasis is a primary cause of mortality in colorectal cancer (CRC).
• The specific role of microRNA-222 (miR-222) in CRC cell invasion and migration is not well understood.
• miR-222 is implicated as an oncogene in various cancer types.

Purpose of the Study:

• To investigate the function of miR-222 in colorectal cancer cell invasion and migration.
• To identify the downstream signaling pathways regulated by miR-222 in CRC.
• To evaluate miR-222 as a potential therapeutic target for CRC.

Main Methods:

• Utilized cell culture models of colorectal cancer (CRC) with miR-222 overexpression and interference.
• Performed bioinformatic analysis and dual luciferase reporter assays to identify miR-222 targets.
• Conducted in vivo experiments by transplanting HCT116 cells overexpressing miR-222 into nude mice.
• Assessed the impact of miR-222 and MST3 on cell migration, invasion, and paxillin phosphorylation.

Main Results:

• Overexpression of miR-222 significantly enhanced migration and invasion of CRC cell lines.
• Interference with miR-222 inhibited CRC cell migration and invasion.
• Mammalian STE20-like protein kinase 3 (MST3) was identified as a direct target of miR-222.
• Downregulation of MST3 promoted CRC cell migration and invasion, while MST3 overexpression attenuated miR-222's effects.
• In vivo studies showed increased lung metastases in mice with xenografted miR-222-overexpressing HCT116 cells.
• MST3's mechanism may involve regulating paxillin phosphorylation, cell adhesion, or invadopodia formation.

Conclusions:

• miR-222 plays a critical role in regulating colorectal cancer cell migration and invasion by modulating MST3.
• The miR-222/MST3 axis represents a significant pathway in CRC progression.
• miR-222 emerges as a promising novel therapeutic target for colorectal cancer treatment.